HomeVNDA • NASDAQ
Vanda Pharmaceuticals Inc.
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 52.59M | 4.19% |
Operating expense | 88.36M | 52.64% |
Net income | -27.21M | -502.19% |
Net profit margin | -51.73 | -477.99% |
Earnings per share | — | — |
EBITDA | -36.49M | -346.14% |
Effective tax rate | 22.01% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 325.55M | -16.03% |
Total assets | 624.75M | -4.09% |
Total liabilities | 138.42M | 27.16% |
Total equity | 486.33M | — |
Shares outstanding | 59.09M | — |
Price to book | 0.51 | — |
Return on assets | -15.32% | — |
Return on capital | -18.85% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -27.21M | -502.19% |
Cash from operations | -15.25M | -120.15% |
Cash from investing | -15.27M | -0.05% |
Cash from financing | -425.00K | — |
Net change in cash | -30.81M | -38.77% |
Free cash flow | -5.33M | 39.52% |
Previous close
$4.20
Day range
$4.22 - $4.28
Year range
$3.81 - $5.54
Market cap
250.27M USD
Avg Volume
510.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2002
Headquarters
Website
Employees
368
